This invention concerns cranial vasculature health and assessment of health or disorder, and in particular concerns use of a recently discovered signal caused by pulsing of blood through the head during sleep.
What is called herein the headpulse is a novel biological phenomenon measurable in mammals, notably humans, involving a mechanical force on the head and brain produced by the cardiac contraction and subsequent blood flow into the brain. The headpulse has been measured by a device attached against the head, specifically a highly sensitive accelerometer, providing a time-domain varying signal. The same device has been used to measure headpulse of LVO (large vessel occlusion) stroke patients and has been useful in determining conditions of stroke and possible indications that a stroke could occur. Even in dogs the headpulse has been detected.
The invention is concerned with measuring the headpulse during sleep, using cranial accelerometry.
Just prior to sleep, after a varying latency from sleep onset (e.g. 3 to 20 minutes) the accelerometer device reveals intermittent dyschronous forces or “bursts” with 1 to 5 spikes that are higher in amplitude than the surrounding headpulse background by as much as 3 to 5 times the amplitude of the typical interburst levels. The spikes can be are spaced 3-5 seconds apart with the entire burst up to about 20 seconds. In many cases these sleep bursts occur regularly at a period fixed for the individual subject, but typically every 20-50 seconds while they are occurring (there may be periods without the bursts). These recurrent bursts in headpulse power can be called Headpulse Sleep Bursts (HPSB).
The burst begins just after sleep onset, and typically maintains constant throughout the night, ceasing somewhat before the subject awakens because of some stimulus, such as needing to visit the bathroom, or an alarm or other sound that has not yet awakened the subject.
This phenomenon is believed to represent glymphatic functions of the mammalian brain, indicating that the brain uses the force resulting from the higher headpulse spike to physically pressurize the brain to expel interstitial fluids into the perivenular spaces. It is a significant force being at least three times normal amplitude, thus involving significant pressure in the brain. There are no known non-invasive methods to measure human brain glymphatic functions. This is the only known technique to non-invasively measure human brain glymphatic function.
Brain glymphatic function may be the central reason why mammals sleep, and dysfunction of this system has been hypothesized to be a causal factor in human neurodegenerative disease. Measurements of patients with mild cognitive impairment (MCI) has shown a dramatic decrease in the number of sleep spikes during sleep. Measuring sleep bursts, and quantifying their frequency, number, power and individual variances, then provides non-invasive information that predicts the onset or progression of neurodegenerative disorders, and therefore may be used to diagnose sleep function and disfunction. Use of the device will have important application as a research device for use by sleep researchers.
The sleep bursts are a novel biological marker that appears only during sleep, and it may have several yet unexpected and unknown uses in health and disease. The signal has been detected and measured in every subject tested. Every one of dozens of tested subjects with no neurological disease exhibits this phenomenon. Variance from the typical burst pattern of a healthy person may be an important diagnostic tool.
Sleep bursts or spikes, their presence or absence, and characteristics, may be used as a biological marker, especially when detected by a wearable device with a three-axis accelerometer, as follows:
The accelerometry data derived according to the invention, energy versus time for multiple heartbeats, is referred to herein as the HeadPulse. The heartbeat is the period of one cardiac cycle, corresponding to the R-R interval (ECG QRS peak representing the peak of systole) from one heartbeat to the next. The heartbeat, i.e. the R-R interval, can be used to parse the HeadPulse recording into multiple data samples wherein each data sample represents the accelerometer in a time domain for one heartbeat.
In the drawings,
In
As indicated in the diagram, the system includes an analyzer 18, which can be onboard the headset 14 or separate, communicating to receive data from the headset. A communication interface 20 is indicated on the headset, for an embodiment in which the analyzer 18 is separate from the headset and wirelessly connected. In another embodiment data can be stored in memory in the headset 14, and communicated later, such as after the patient awakens, to the analyzer 18. In a specific embodiment the analyzer 18 is contained in a smartphone and receives data wirelessly from the headset. In such an embodiment the transfer of data to the analyzer 18 need not be wireless, but can be by a wired connection to the headset after the period of sleep analysis. Alternatively, the data can be stored on a removable memory, such as a memory card, flash card, memory stick, etc., and can be moved to the analyzer 18 to transfer the data at an appropriate time.
Other arrangements are also possible, and it should be understood that the headset can be self-contained, so as to be connectable to a smartphone either by wire or wirelessly after a sleep session, or data can be sent contemporaneously to the smartphone throughout the sleep session. Another arrangement is for the analyzer 18 to be completely contained on the headset or wearable device in contact with the head.
As is known, the heartbeat produces a force on the head and neck, through the cerebral vasculature. The force on the brain produced by the heartbeat is transferred to the skull. When the subject is prone during sleep, the force of blood entering the brain in the vertical or X-axis direction (vertical referring to the head when upright), can more freely move the brain and other tissues, not being restrained by gravity along that axis. The head 22 of the subject 12 moves in response to each heartbeat, heartbeats being indicated at 24, 26 and 28 and the heart being indicated at 30. In the illustrated system the accelerations (indicated at 32) of the head are detected with the accelerometer 16, ultimately to enable a plot with a waveform of accelerations/head movements against time with the acquired data.
A power supply for the headset is indicated at 36.
The accelerometer 16 detects acceleration in at least one direction or axis, and generates an accelerometer signal based on the acceleration of the head. The most important axis for purposes of this invention is the vertical axis relative to a standing person, denoted herein as the X axis 38 in
The headset is represented in the block diagram of
A controller 54 is also shown in
Converted digital data 46a are retrieved from the memory 48 and transmitted to the analyzer 18, which can be separate from the headset as indicated in the example of
The horizontal axis in the charts is in seconds of time, spanning about three hours, while the vertical axis basically indicates energy of the acceleration movements, in each of the X, Y and Z waveforms. The X waveform, i.e. the vertical acceleration movements of the cranium (vertical referring to a standing person), is the waveform of greatest interest. As noted above, the supine subject has brain and cranial movements, induced by pulse, that are not restrained by gravity in the X axis. Thus, the periodic spike is exhibited most prominently on the X axis. In this example the periodic spikes are noted at 72, that first appear after falling asleep, occurring for this subject approximately at 45 to 50 second intervals (13 or 14 spikes per ten minutes). The subject's heartbeat, displayed in the bottom waveform, is shown in coordination with the X, Y and Z waveforms for timing. The main spikes 72 generally occur every 20 to 50 seconds.
As explained above, the sleep spike or burst phenomenon appears connected with housekeeping functions of the brain that normally occur during sleep, such as cleaning out of interstitial fluid and cells and to refresh the brain during sleep. It is believed that a patient with a brain disorder, which may be dementia, concussion, moderate to severe traumatic brain injury, or other serious neurodegenerative disorders or conditions, or even insomnia, will exhibit either a lack of sleep burst, maldistribution of sleep bursts or significantly greater intervals between sleep bursts.
It is theorized that the sleep bursts or spikes occur only at intervals of 20 to 50 seconds to provide a brain cleansing function. By reporting the number of sleep bursts one can report the quality of brain cleaning during a night of sleep.
The invention can enable analysis of a subject during sleep, with an investigation of sleep spikes to determine whether the subject may be suffering from a disease or abnormal brain condition or function. It can document the consequences of sleep description and the quality of sleep recovering on subsequent sleep episodes. It can inform a person if a nap was beneficial. It may be used as a method to tell if someone is having microsleeps (brief episodes of sleep during the day), as would be useful to know prior to driving a car or flying a plane. It can be useful to tell whether a person's complaint of memory loss is due to a neurodegenerative disease or psychiatric disease or medication side effect.
Materials and Methods: Adult volunteers consented to have headpulse and sleep profiling measurements during normal sleep. The headpulse was recorded from a custom UCSF-designed device worn as a hairband containing force transducers in contact with the temporal scalp anterior to the right ear. These signals were digitized and stored on a memory card on the battery powered headset, and signals were analyzed in custom software written in MATLAB (Math Works, Natick, MA, USA). Sleep profiling was accomplished using the Sleep Profiler (SP) (Advanced Brain Monitoring, Carlsbad, CA). Sleep stages were automatically detected from the device and edited in standard 30 sec intervals. The timing of SP and HP recordings were aligned and analyzed in register.
Results: In one particular clinical trial 18 volunteer subjects were consented to allow combined SP and HP recordings during a normal night of sleep. This included 9 female and 9 male subjects. Average age was 41.9 years (IQR 24.8-61.5). A total of 297 hours of combined HP and SP recordings were obtained. Headpulse recording revealed transient increases in forces beginning just prior to the onset of sleep determined by polysomnographic distribution and repeatable variation in occurrence over the sleep period. We termed this phenomenon as HeadPulse Sleep Bursts (HPSB). HPSBs were observed in 9/9 (100%) of subjects. The number of HPSBs in subjects with a full night of sleep ranged from 100-500. Overall, HPSB occurred at a mean frequency of 0.65 HPSB/min (SD 0.34), or (0.01 Hz) for the whole epoch of sleep but typically occurred in runs of every 20-50 seconds (0.02-0.05 Hz) interspersed with minutes of no bursts. In some subjects the timing of HPSB was remarkably periodic happening every 50 seconds in one subject and every two minutes in another. Using the awake period just prior to sleep as the reference, HPSB occurred 1.16, 1.42, 1.07, and 0.84 times more frequent in REM, N1, N2 and N3 sleep stages. The frequency of N2 stage HPSB frequency was marginally significant compared to awake (p=0.49, T-test). Normal subjects who had headpulse recording in the seated or supine position were at a rate of 0.1 bursts/minute, but it was difficult to separate gross body motion from what would be typical of a sleep burst.
Conclusions: This is the first report of HPSB phenomenon in humans or mammals. HPSB occurred in 100% of recorded subjects and is mostly independent of sleep stage. HPSB began during wakefulness just prior to sleep onset in all subjects and are not present in awake subjects not preparing for sleep. The relative low frequency of these bursts in the 20-50 second range (0.02-0.05 HZ) has no parallel in human sleep profiles but does match that seen with transient reversal of CSF flow in the cerebral aqueduct in sleeping humans measure on MRI, and the frequency of locus coeruleus discharges in sleep. The presence only during sleep indicates this is linked to mammalian glymphatic drainage and therefore could be a novel biomarker for this putative cleansing mechanism during sleep.
The above described preferred embodiments are intended to illustrate the principles of the invention, but not to limit its scope. Other embodiments and variations to these preferred embodiments will be apparent to those skilled in the art and may be made without departing from the spirit and scope of the invention as defined in the following claims.
This application claims benefit of provisional application Ser. No. 63/580,325, filed Sep. 1, 2023.
Number | Date | Country | |
---|---|---|---|
63580325 | Sep 2023 | US |